@extends('layouts/main-layout') @section('meta_title') Dr Vatchsala Sree Varadharajan @endsection @section('meta_description') Dr. Kumar Prabhu, an Urology Specialist in Bangalore working for NU Hospitals India is quite a famous name when it comes to male and female Urethral Reconstruction Surgeon. @endsection @section('meta_keywords') @endsection @section('canonical') https://www.nuhospitals.com/ @endsection @section('custom-css') @endsection @section('content')
Dr. Vatchsala Sree Varadharajan

Cardiology


MBBS, MRCP (UK), MD (UK)


Consultant Cardiologist – Dept. of Cardiology, KM NU Hospitals, Ambur

Appointment Icon for KMNU Hospitals - Schedule Your Visit
Book an Appointment
Book an Appointment Icon - KMNU Hospitals
Book a Video Consultation

OVERVIEW


Dr. Vatchsala is an enthusiastic cardiologist who is highly motivated and has abundant experience in cardiology. She has worked in NHS UK for 7 years and has brought in all the international expertise to the rural population of Tamil Nadu. She is committed in delivering quality patient care through multidisciplinary approach and collaborative learning. She has proven ability to adapt to changes and persevere towards common goals while maintaining the team effectiveness. She has excellent communication skills and can relate well to her patients and colleagues. Above all she has the commitment to provide the best of patient care.

Qualifications:

  • MD 2010- 2016 University of Sheffield, UK
  • MPhil 2005- 2010 University of Sheffield, UK
  • MRCP 2004 Royal College of Physicians, UK
  • MBBS 1998 Dr MGR Medical University, Tamil Nadu

Presentations:

International

  • 2010: CRT for heart failure, Grand round presentation, Rotherham district General hospital
  • 2009: Syncope, Grand round presentation, Rotherham district General hospital
  • 2007: Safety of enoxaparin in the management of ACS, Regional audit meeting, Barnsley
  • 2007: Interpretation of ECG, Teaching for SHO, Sheffield teaching hospitalsm,NHS foundation trust
  • 2007: Management of ACS, Monthly Audit meeting, Sheffield teaching hospitals, NHS Foundation trust
  • 2006: Safety of enoxaparin in the management of ACS, Grand round meeting, Sheffield teaching hospitals, NHS foundation trust
  • 2004: RVOT VT, Cardiology meeting, University Hospital Aintree, Liverpool
  • 2003: Small bowel infarction secondary to Volvulus, SHO MRCP teaching, Royal Albert Edward infirmary, Wigan
  • 2003: Half of what doctors know Is wrong?, Grand round meeting, Princess of Wales Hospital

National Conference

  • 2020 Diastolic Heart Failure APICON/Agra
  • 2019 How to perform 2D strain ECHO India/Kolkata
  • 2019 Workshop- Strain analysis ECHO India/Kolkata
  • 2019 AR- When to intervene ECHO India/Kolkata
  • 2018 Strain analysis in ECHO ECHO India/ Chennai
  • 2018 Artifacts in ECHO ECHO India/Chennai
  • 2017 P2Y12 inhibitor India Live/Delhi
  • 2017 Redefining LVH WCCICC/Bombay
  • 2016 Aortic Stenosis ECHO/Madurai
  • 2016 Aorto Left Atrial Tunnel ECHO /Madurai
  • 2016 SPRINT to lower BP Coimbatore
  • 2016 SPRINT Kolkata

State Conference

  • 2019 Non cardiac causes for ST elevation ISSICON/Tuticorin
  • 2019 Heart block ISSICON/Tuticorin
  • 2019 ECHO- Current Era TAPICON/ Madurai
  • 2019 Strain guided therapy in CAD TANCSI/ Munnar
  • 2018 ACLS/BLS NHC/ Madurai
  • 2018 Strain guided therapy in CAD TANCSI/ Rameswaram
  • 2018 Diabetic Cardiomyopathy DIATCON/Trichy
  • 2017 Newer therapeutic options in HF management STEMI conclave/ Amritsar
  • 2017 Tight glycaemic control and CVD risk GCDC/Chennai
  • 2017 Debate on device therapy for VF arrest TAPICON/Chennai
  • 2016 Telmisartan and CV risk reduction Mysore/India
  • 2016 Thrombolysis in STEMI TAPICON/Tuticorin
  • 2016 Newer CAD risk markers TANCSI/Tuticorin
  • 2016 Platelet function Testing TIC meet/ Chennai
  • 2016 EMPA- REG outcome trial Vellore/India
  • 2016 SGLT-2 inhibitors IMA/Tiruvannamalai
  • 2016 SGLT-2 inhibitor Diabetic club/Trichy
  • 2016 Differentiation of Gliptins Diabetic club/Kanchi

Regional Conference

  • 2019 Role of Ivabradine in HF Chennai
  • 2019 ACS for GP Vellore
  • 2019 Chest Pain assessment IMA Ranipet
  • 2019 Peripartum Cardiomyopathy IMA Ranipet
  • 2019 SGLT 2Inhibitors Vellore/India
  • 2018 Azilsartan Cardioclub/Vellore
  • 2017 ECHO in paediatric cardiology IMA/Vellore
  • 2017 Advanced ECG interpretation Vellore/India
  • 2017 Heart failure trials so far…. Vellore/India
  • 2016 Link between cardio & dentistry Vellore/India
  • 2014 Case Presentation Chennai/India
  • 2014 CV Protection of Gliptins Vellore/India
  • 2014 Cardio Diabeto Pharmacology Vellore/India
  • 2014 Preoperative assessments Vellore/India
  • 2014 Diabetes in cardiology Vellore /India
  • 2013 Hypertensive emergencies Vellore/India
  • 2012 Advanced management of ACS Vellore/India
  • 2011 ECG interpretation Vellore/India
  • 2011 Statins in Primary Prevention Vellore/India
  • 2011 Hypertension in Diabetes Vellore/India
  • 2011 Cardiogenic Shock Vellore/India
  • 2010 Current trends in the management of ACS Vellore/India

Publications:

  • Won first place for a poster presentation at the TIC meet Chennai
  • E Letter to BMJ.Com 10 Feb 2003 ww.bmj.com/cgi/content/extract/338/jan07_1/b8
  • E Letter to BMJ.Com 9 September 2004. bmj.bmjjournals.com/cgi/content/full/329/7465/557
  • Symptomatic hypertrophic obstructive cardiomyopathy-semi-supine bicycle ergometry as a useful provocative manoeuvre to elicit latent gradient. BMJ case report 2009 doi: 10.1136/bcr.10.2008.1044

Projects:

Cardiology (UK)

  • Safety of enoxaparin in the treatment of ACS- Sheffield Teaching Hospitals NHS Foundation Trust
  • Safety of enoxaparin in the treatment of ACS in elderly patients- Sheffield Teaching Hospitals NHS Foundation Trust
  • Management of ACS in Sheffield Teaching Hospital NHS Foundation Trust
  • Secondary prevention following STEMI- RAEI Wigan
  • Congestive Cardiac Failure – Treatment and Readmission, RAEI, Wigan

Others (UK)

  • Case notes audit in the cardiology directorate-University Hospital Aintree
  • A prospective study to evaluate the management of upper GI cancer patients within the trust-RAEI/Wigan [Nov 03-Apr 04]
  • The use of NICE approved drugs in the management of Lymphoproliferative Malignancies-Department of Haematology, RAEI
  • Documentation Audit of Drug Cards in General Medical Wards at QE II Hospital, Welwyn Garden City
  • Hand Washing in General Medicine at QE II Hospital
@endsection @section('custom-js') @endsection